...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl) phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors
【24h】

Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl) phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors

机译:6-(哌嗪-1-基)菲啶的新型酰胺和磺酰胺衍生物可作为有效的结核分枝杆菌H37Rv抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

A series of thirty three novel 6-(piperazin-1-yl)phenanthridine amide and sulphonamide analogues were synthesized, characterized and screened for their in vitro antimycobacterial activity against Mycobacterium tuberculosis (MTB) H37Rv strain. These compounds exhibited minimum inhibitory concentration (MIC) between 1.56 and >= 50 mu g/mL. Out of these derivatives, few compounds 61, 6r, 7b, 7f, 7g and 7k exhibited moderate activity (MIC = 6,25 mu g/mL) and compounds 6b, 6e, 6k, 6n, 7h, 7i and 7n displayed good activity (MIC = 3.13 mu g/mL), whereas compounds 6m, 6s and 7d exhibited excellent anti-tubercular activity (MIC = 1.56 mu g/mL). In addition, MIT assay was accomplished on the active analogues of the series against mouse macrophage (RAW 264.7) cells to evaluate the toxicity profile of the newly synthesized compounds and selectivity index of the compounds was determined. Additionally, compounds 6b and 7d were docked to the ATPase domain of M. tuberculosis GyrB protein to know the interaction profile and structures of compounds 6b and 7d were further substantiated through single crystal XRD. (C) 2015 Elsevier Masson SAS. All rights reserved.
机译:合成,表征,筛选了一系列的三十三个新颖的6-(哌嗪-1-基)菲啶酰胺和磺酰胺类似物对结核分枝杆菌(MTB)H37Rv菌株的体外抗分枝杆菌活性。这些化合物的最小抑菌浓度(MIC)在1.56和> = 50μg / mL之间。在这些衍生物中,很少有化合物61、6r,7b,7f,7g和7k表现出中等活性(MIC = 6.25μg / mL),化合物6b,6e,6k,6n,7h,7i和7n表现出良好的活性。 (MIC = 3.13μg / mL),而化合物6m,6s和7d表现出优异的抗结核活性(MIC = 1.56μg / mL)。另外,在针对小鼠巨噬细胞(RAW 264.7)细胞的系列活性类似物中完成了MIT测定,以评估新合成的化合物的毒性概况并确定了化合物的选择性指数。另外,将化合物6b和7d对接至结核分枝杆菌GyrB蛋白的ATPase结构域,以了解化合物6b和7d的相互作用概况和结构可通过单晶XRD进一步证实。 (C)2015 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号